See more : PT Jakarta Setiabudi Internasional Tbk (JSPT.JK) Income Statement Analysis – Financial Results
Complete financial analysis of Tata Chemicals Limited (TATACHEM.BO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Tata Chemicals Limited, a leading company in the Chemicals industry within the Basic Materials sector.
- Human Health Holdings Limited (1419.HK) Income Statement Analysis – Financial Results
- DOD Biotech Public Company Limited (DOD.BK) Income Statement Analysis – Financial Results
- Tai United Holdings Limited (0718.HK) Income Statement Analysis – Financial Results
- Image Metrics, Inc. (IMGX) Income Statement Analysis – Financial Results
- Social Leverage Acquisition Corp I (SLAC-UN) Income Statement Analysis – Financial Results
Tata Chemicals Limited (TATACHEM.BO)
About Tata Chemicals Limited
Tata Chemicals Limited manufactures, sells, and distributes basic chemistry and specialty products in India, Europe, Africa, the United States, rest of Asia, and internationally. It offers dense, heavy, and light soda ash; caustic soda, chlorine and bromine-based products, gypsum, sodium bicarbonate, sodium chloride, crushed refined soda, and livestock and dry industrial salt; Crex; energy; and Portland and masonry cement under the Tata Shudh brand name. The company also provides nano zinc oxides and silica; prebiotics and dietary fibers; insecticides, herbicides, fungicides, organic fertilizers, and plant growth nutrients; and energy storage solutions. Its products are used in various industrial applications, such as agriculture; animal nutrition; chemicals; construction; food and nutrition; glass; high performance rubber; metals; oral care and cosmetics; paints, inks, and adhesives; pharmaceuticals; safety and environment; soaps and detergents; textiles and leather; lithium-ion, dry cell, and other batteries; and others. Tata Chemicals Limited was founded in 1927 and is based in Mumbai, India.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 154.21B | 166.80B | 125.17B | 100.89B | 102.52B | 102.60B | 101.81B | 103.46B | 133.20B | 139.70B | 132.96B | 121.60B | 108.18B | 110.61B | 94.49B | 126.52B | 59.82B | 57.63B | 40.34B |
Cost of Revenue | 95.88B | 38.01B | 30.15B | 26.80B | 23.08B | 23.42B | 20.99B | 23.99B | 62.46B | 72.56B | 65.24B | 60.21B | 58.35B | 60.40B | 77.04B | 108.86B | 49.79B | 71.67B | 18.26B |
Gross Profit | 58.33B | 128.79B | 95.02B | 74.09B | 79.44B | 79.18B | 80.82B | 79.47B | 70.74B | 67.14B | 67.71B | 61.39B | 49.83B | 50.20B | 17.45B | 17.66B | 10.03B | -14.04B | 22.08B |
Gross Profit Ratio | 37.83% | 77.21% | 75.91% | 73.44% | 77.49% | 77.18% | 79.38% | 76.81% | 53.11% | 48.06% | 50.93% | 50.48% | 46.06% | 45.39% | 18.47% | 13.96% | 16.76% | -24.35% | 54.73% |
Research & Development | 0.00 | 860.00M | 680.00M | 700.00M | 45.10M | 364.30M | 337.50M | 349.60M | 842.80M | 1.11B | 511.80M | 151.50M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 1.23B | 910.00M | 820.00M | 631.70M | 454.20M | 350.30M | 322.20M | 330.10M | 382.80M | 434.40M | 438.90M | 381.60M | 341.00M | 4.10B | 0.00 | 0.00 | 13.80B | 12.22B | 7.18B |
Selling & Marketing | 26.63B | 26.42B | 22.05B | 17.68B | 18.38B | 19.20B | 20.94B | 20.78B | 23.97B | 27.94B | 25.78B | 22.67B | 20.18B | 13.59B | 0.00 | 0.00 | 5.96B | 5.57B | 4.25B |
SG&A | 38.22B | 27.33B | 22.87B | 18.31B | 18.84B | 19.55B | 21.26B | 21.11B | 24.36B | 28.38B | 26.21B | 23.05B | 20.52B | 17.69B | 0.00 | 0.00 | 19.76B | 17.80B | 11.43B |
Other Expenses | 1.07B | 360.00M | 390.00M | 666.50M | 587.70M | 511.00M | 78.00M | 374.90M | 128.80M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating Expenses | 39.29B | 98.88B | 79.64B | 66.38B | 66.32B | 66.81B | 63.84B | 63.40B | 54.19B | 48.17B | 55.04B | 43.23B | 31.16B | 35.98B | 7.75B | 8.49B | -1.73B | 26.72B | 16.07B |
Cost & Expenses | 135.17B | 136.89B | 109.79B | 93.18B | 89.41B | 90.22B | 84.84B | 87.39B | 116.66B | 120.73B | 120.29B | 103.44B | 89.51B | 96.38B | 84.79B | 117.35B | 48.06B | 98.39B | 34.34B |
Interest Income | 410.00M | 750.00M | 1.15B | 747.60M | 605.30M | 1.02B | 386.50M | 607.10M | 274.40M | 367.90M | 662.00M | 171.40M | 365.70M | 145.00M | 0.00 | 0.00 | 0.00 | 0.00 | 185.50M |
Interest Expense | 4.30B | 3.25B | 2.27B | 2.86B | 2.67B | 3.02B | 2.58B | 3.34B | 3.42B | 4.21B | 4.51B | 4.24B | 3.74B | 3.51B | 0.00 | 0.00 | 0.00 | 0.00 | 469.50M |
Depreciation & Amortization | 9.79B | 8.90B | 8.05B | 7.59B | 6.66B | 5.68B | 5.18B | 5.12B | 5.71B | 4.63B | 4.71B | 5.34B | 5.09B | 4.47B | 4.42B | 4.17B | 3.07B | 2.71B | 1.82B |
EBITDA | 21.71B | 39.57B | 24.73B | 16.53B | 21.85B | 22.07B | 24.33B | 23.90B | 20.94B | 20.76B | 5.32B | 18.81B | 22.66B | 18.92B | 14.54B | 13.40B | 14.90B | -38.02B | 7.85B |
EBITDA Ratio | 14.08% | 23.51% | 21.31% | 15.98% | 19.74% | 19.75% | 22.64% | 22.77% | 15.77% | 15.94% | 7.73% | 19.46% | 22.12% | 17.65% | 15.39% | 10.59% | 24.90% | -65.97% | 19.45% |
Operating Income | 19.04B | 29.90B | 15.25B | 7.70B | 13.19B | 12.36B | 16.88B | 15.47B | 15.96B | 17.64B | 5.57B | 18.33B | 18.21B | 14.22B | 9.33B | 9.17B | 11.76B | -40.76B | 6.01B |
Operating Income Ratio | 12.35% | 17.93% | 12.18% | 7.63% | 12.86% | 12.05% | 16.58% | 14.95% | 11.98% | 12.63% | 4.19% | 15.07% | 16.83% | 12.86% | 9.87% | 7.25% | 19.66% | -70.72% | 14.89% |
Total Other Income/Expenses | -10.74B | -2.50B | -22.71B | -52.10B | -638.10M | 2.00B | -771.20M | -1.40B | -4.75B | -4.42B | -17.86B | -9.02B | -4.37B | -3.01B | 0.00 | 0.00 | -100.00K | 48.19B | -55.20M |
Income Before Tax | 8.30B | 27.40B | 16.67B | 6.34B | 12.48B | 14.37B | 16.20B | 14.67B | 11.80B | 11.59B | -5.19B | 9.13B | 13.83B | 11.21B | 9.33B | 9.17B | 11.76B | 7.48B | 6.01B |
Income Before Tax Ratio | 5.38% | 16.43% | 13.32% | 6.28% | 12.17% | 14.01% | 15.91% | 14.18% | 8.86% | 8.29% | -3.90% | 7.51% | 12.79% | 10.13% | 9.87% | 7.25% | 19.66% | 12.98% | 14.89% |
Income Tax Expense | 3.81B | 2.88B | 2.67B | 1.98B | 2.20B | 2.74B | 601.30M | 3.46B | 2.48B | 3.51B | 2.89B | 3.03B | 3.44B | 2.75B | 2.09B | 1.58B | 2.11B | 2.40B | 1.72B |
Net Income | 2.68B | 23.17B | 12.58B | 2.56B | 70.06B | 11.56B | 24.33B | 9.93B | 7.71B | 5.96B | -10.32B | 4.00B | 8.38B | 8.46B | 7.24B | 7.60B | 9.64B | 5.08B | 4.28B |
Net Income Ratio | 1.74% | 13.89% | 10.05% | 2.54% | 68.34% | 11.27% | 23.90% | 9.60% | 5.78% | 4.27% | -7.76% | 3.29% | 7.74% | 7.65% | 7.66% | 6.01% | 16.12% | 8.82% | 10.62% |
EPS | 10.52 | 90.95 | 49.37 | 10.06 | 275.02 | 45.37 | 95.51 | 38.98 | 30.25 | 23.41 | -40.51 | 15.72 | 32.88 | 26.10 | 25.61 | 27.59 | 43.51 | 23.62 | 19.91 |
EPS Diluted | 10.52 | 90.95 | 49.37 | 10.06 | 275.02 | 45.37 | 95.51 | 38.98 | 30.25 | 23.41 | -40.51 | 15.72 | 32.88 | 26.10 | 25.61 | 26.19 | 38.52 | 20.93 | 17.80 |
Weighted Avg Shares Out | 254.75M | 254.76M | 254.76M | 254.76M | 254.76M | 254.76M | 254.76M | 254.76M | 254.76M | 254.76M | 254.76M | 254.76M | 254.76M | 250.35M | 236.57M | 234.89M | 221.67M | 215.10M | 215.10M |
Weighted Avg Shares Out (Dil) | 254.76M | 254.76M | 254.76M | 254.76M | 254.76M | 254.76M | 254.76M | 254.76M | 254.76M | 254.76M | 254.76M | 254.76M | 254.76M | 250.35M | 243.26M | 243.47M | 243.47M | 243.47M | 243.47M |
Source: https://incomestatements.info
Category: Stock Reports